Józef Kładny

3.0k total citations
65 papers, 1.9k citations indexed

About

Józef Kładny is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Józef Kładny has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Molecular Biology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Józef Kładny's work include Genetic factors in colorectal cancer (17 papers), BRCA gene mutations in cancer (11 papers) and DNA Repair Mechanisms (7 papers). Józef Kładny is often cited by papers focused on Genetic factors in colorectal cancer (17 papers), BRCA gene mutations in cancer (11 papers) and DNA Repair Mechanisms (7 papers). Józef Kładny collaborates with scholars based in Poland, Australia and Canada. Józef Kładny's co-authors include Jan Lubiński, Cezary Cybulski, Bohdan Górski, Tadeusz Dębniak, Tomasz Huzarski, Grzegorz Kurzawski, Jacek Gronwald, Tomasz Byrski, Rodney J. Scott and Anna Jakubowska and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Józef Kładny

63 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Józef Kładny Poland 25 1.0k 544 458 368 355 65 1.9k
Tae Sook Hwang South Korea 26 385 0.4× 525 1.0× 698 1.5× 221 0.6× 162 0.5× 77 2.0k
Hiroshi Obata Japan 26 607 0.6× 873 1.6× 496 1.1× 291 0.8× 525 1.5× 106 3.8k
Bernard Drénou France 30 797 0.8× 185 0.3× 579 1.3× 421 1.1× 136 0.4× 98 2.8k
Leticia Moreira Spain 21 860 0.9× 494 0.9× 758 1.7× 622 1.7× 709 2.0× 85 2.3k
J Piris United Kingdom 26 820 0.8× 910 1.7× 428 0.9× 396 1.1× 208 0.6× 54 2.8k
Alexander Watson United Kingdom 23 360 0.4× 422 0.8× 260 0.6× 186 0.5× 94 0.3× 71 2.0k
Hyo-Suk Lee South Korea 28 435 0.4× 605 1.1× 871 1.9× 337 0.9× 564 1.6× 56 3.1k
Arnold Mittelman United States 27 1.4k 1.4× 705 1.3× 605 1.3× 458 1.2× 213 0.6× 98 2.7k
F. Brunello Italy 20 205 0.2× 573 1.1× 249 0.5× 265 0.7× 167 0.5× 51 3.0k
Mee Soo Chang South Korea 26 744 0.7× 460 0.8× 515 1.1× 341 0.9× 299 0.8× 106 2.2k

Countries citing papers authored by Józef Kładny

Since Specialization
Citations

This map shows the geographic impact of Józef Kładny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Józef Kładny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Józef Kładny more than expected).

Fields of papers citing papers by Józef Kładny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Józef Kładny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Józef Kładny. The network helps show where Józef Kładny may publish in the future.

Co-authorship network of co-authors of Józef Kładny

This figure shows the co-authorship network connecting the top 25 collaborators of Józef Kładny. A scholar is included among the top collaborators of Józef Kładny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Józef Kładny. Józef Kładny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sulżyc‐Bielicka, Violetta, Lidia Kołodziejczyk, Małgorzata Adamska, et al.. (2021). Colorectal cancer and Blastocystis sp. infection. Parasites & Vectors. 14(1). 200–200. 30 indexed citations
2.
Kładny, Józef, et al.. (2021). Factors determining the quality of life in patients undergoing radical surgery due to malignant tumors of the rectum. Polish Journal of Surgery. 93(3). 1–5. 2 indexed citations
3.
Jankowski, Michał, Andrzej Rutkowski, Wojciech Zegarski, et al.. (2021). The surgical treatment of rectal cancer in Poland. The findings of a multi-center observational study by the Polish Society of Surgical Oncology (PSSO-01). SHILAP Revista de lepidopterología. 71(5). 282–289. 2 indexed citations
4.
Baszuk, Piotr, Paulina Stadnik, Wojciech Marciniak, et al.. (2021). Low Blood-As Levels and Selected Genotypes Appears to Be Promising Biomarkers for Occurrence of Colorectal Cancer in Women. Biomedicines. 9(9). 1105–1105. 1 indexed citations
5.
Lubiński, Jan, Wojciech Marciniak, Magdalena Muszyńska, et al.. (2017). Serum selenium levels predict survival after breast cancer. Breast Cancer Research and Treatment. 167(2). 591–598. 39 indexed citations
6.
Lener, Marcin, Rodney J. Scott, Anna Wiechowska–Kozłowska, et al.. (2015). Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer. Cancer Research and Treatment. 48(3). 1056–1064. 93 indexed citations
7.
Rutkowski, Piotr, Beata Śpiewankiewicz, T Jastrzebski, et al.. (2014). Polish clinical practice guideline on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cytoreductice Surgery (CRS) in peritoneal malignancy treatment. Oncology in Clinical Practice. 10(6). 283–289. 1 indexed citations
8.
Scott, Rodney J., Bohdan Górski, Cezary Cybulski, et al.. (2014). Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population. Molecular Biology Reports. 42(3). 755–764. 30 indexed citations
9.
Lener, Marcin, Satish Gupta, Rodney J. Scott, et al.. (2013). Can selenium levels act as a marker of colorectal cancer risk?. BMC Cancer. 13(1). 214–214. 35 indexed citations
10.
Sulżyc‐Bielicka, Violetta, et al.. (2012). Prevalence of Cryptosporidium sp. In Patients with Colorectal Cancer. Polish Journal of Surgery. 84(7). 348–51. 36 indexed citations
11.
Wojtasik, Piotr, et al.. (2011). Advisability of Palliative Resections in Incurable Advanced Gastric Cancer. Polish Journal of Surgery. 83(8). 449–56. 11 indexed citations
12.
Sulżyc‐Bielicka, Violetta, Paweł Domagała, Maria Chosia, et al.. (2009). Nuclear thymidylate synthase expression in sporadic colorectal cancer depends on the site of the tumor. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 454(6). 695–702. 7 indexed citations
14.
Suchy, Janina, Cezary Cybulski, Dominika Wokołorczyk, et al.. (2009). CHEK2 mutations and HNPCC‐related colorectal cancer. International Journal of Cancer. 126(12). 3005–3009. 33 indexed citations
15.
Byrski, Tomasz, Tomasz Huzarski, Rebecca Dent, et al.. (2008). Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Research and Treatment. 115(2). 359–363. 243 indexed citations
16.
Pietrzak, Lucyna, Krzysztof Bujko, Marek P. Nowacki, et al.. (2007). Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: Report of a randomised trial. Radiotherapy and Oncology. 84(3). 217–225. 123 indexed citations
17.
Wojtasik, Piotr, et al.. (2005). [Stromal tumour of the small intestine as a rare cause of gastrointestinal bleeding].. PubMed. 58(5-6). 350–2.
18.
Kurzawski, Grzegorz, Tadeusz Dębniak, Józef Kładny, & Jan Lubiński. (2001). Age at diagnosis of cancer as predictor of mutation occurrence in families suspected of HNPCC.. PubMed. 42(3). 359–66. 1 indexed citations
19.
Dębniak, Tadeusz, Bohdan Górski, Cezary Cybulski, et al.. (2001). Comparison of Alu-PCR, microsatellite instability, and immunohistochemical analyses in finding features characteristic for hereditary nonpolyposis colorectal cancer. Journal of Cancer Research and Clinical Oncology. 127(9). 565–569. 7 indexed citations
20.
Lubiński, Jan, Stanisław Zajączek, Józef Kładny, et al.. (1996). Hereditary tumors - prophylactics, early diagnosis, treatment. Biotechnologia. 201–207.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026